arrow
M

Maiken Cavling Arendrup

Statens Serum Institut
H指数:84
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antifungal Resistance Surveillance: Insights From National Mycology Reference Centers and Expert Mycology Laboratories

抗真菌耐药性监测:国家真菌学参考中心和专家真菌学实验室的见解

2026-01-010
OAAI
Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III Study

持续念珠菌血症的危险因素及预后意义:ECMM Candida III 研究结果

2025-10-150
OAAI
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established EUCAST breakpoints

如何根据新建立的EUCAST折点解释米卡芬净、棘白菌素和氟胞嘧啶对耳念珠菌(耳念珠菌)的MIC值

2025-07-110
OAAI
Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology

人类和动物真菌病原体和疾病的命名: 标准化术语的提案

2024-12-110
PRE
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective

真菌优先病原体清单对医学真菌学的影响: 北欧的观点

2024-07-013
OAAI
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

新的抗真菌药物和治疗方法,以解决耐药性并改善侵袭性真菌病的结果

2024-06-1313
PRE
Reply to Kidd et al., Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

对Kidd等人的答复,“稳定真菌命名风险的拟议框架内的不一致” 进一步混淆

2024-04-100
OA